Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
JG.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.42.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HK.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ML.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used